Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Table of contents Zealand Pharma Headquarters: Denmark Technology: GLP-1 receptor agonist Lead candidate: Survodutide Danish biotech company Zealand Pharma is developing peptide therapies to treat metabolic diseases like type 1 diabetes and obesity, as well as rare diseases and inflammatory conditions
Ready to take the right step
Instead of generic plans or short-term fixes, MEDVi focuses on personalized care using GLP-1based medical support that helps regulate appetite, reduce cravings, and support healthy metabolic function over time
Glutathione may support reproductive health by protecting egg and sperm cells from damage, though its effectiveness depends heavily on its bioavailability
Key Benefits & Science: Superior Weight Loss: The SURMOUNT-1 trial showed an average weight loss of 22.5% at the 15 mg dose
US$ 22.69
US$ 20.19
US$ 28.31
US$ 29.76
